A rapid method for determination of four thioamphetamine designer drugs (ALEPH-4, ALEPH-8, ALEPH-13, ALEPH-17) in human urine

Journal of Liquid Chromatography and Related Technologies

Volumn 33, Issue 14, 2010, Pages 1351-1358

  Nieddu, Maria ^a   Boatto, Gianpiero ^a   Pirisi, Maria Antonietta ^a   Dessi, Giuseppina ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

ALEPH 13; ALEPH 17; ALEPH 4; ALEPH 8; ALEPH D3; urine

Indexed keywords

ALEPH-13; ALEPH-17; ALEPH-4; ALEPH-8; ALEPH-D3; URINE;

CAPILLARY ELECTROPHORESIS; EXTRACTION;

BODY FLUIDS;

2,5 DIMETHOXY 4 (2 METHOXYETHYL) THIOAMPHETAMINE; 2,5 DIMETHOXY 4 CYCLOPROPYLMETHYLTHIOAMPHETAMINE; 2,5 DIMETHOXY 4 I BUTYLTHIOAMPHETAMINE; 2,5 DIMETHOXY 4 I PROPYLTHIOAMPHETAMINE; 2,5 DIMETHOXY 4 METHYLTHIOAMPHETAMINE D3; AMPHETAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ANTENNA; ARTICLE; CALIBRATION; CAPILLARY ELECTROPHORESIS; DIODE ARRAY DETECTOR; DRUG DETERMINATION; DRUG IDENTIFICATION; HUMAN; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; URINALYSIS; URINE;

EID: 77956284398     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826076.2010.488991     Document Type: Article

References (16)

1. de Boer, D.; Bosman, I. A New Trend in Drugs-of-abuse: The 2C-series of phenethylamine Designer Drugs. Pharm. World Sci. 2004, 26, 110-113.
2. Theobald, D. S.; Fehn, S.; Maurer, H. H. New Designer Drug, 2,5-dimethoxy-4- propylthio-beta-phenethylamine (2C-T-7): Studies on its Metabolism and Toxicological Detection in Rat Urine Using Gas Chromatography=Mass Spectrometry. J. Mass Spectrom. 2005, 40, 105-116.
3. Vorce, S. P.; Sklerov, J. H. A General Screening and Confirmation Approach to the Analysis of Designer Tryptamines and Phenethylamines in Blood and Urine Using GC-EI-MS and HPLC-electrospray-MS. J. Anal. Toxicol. 2004, 28, 407-410.
4. Habrdova, V.; Peters, F. T.; Theobald, D. S.; Maurer, H. H. Screening for and Validated Quantification of Phenethylamine-type Designer Drugs and Mescaline in Human Blood Plasma by Gas Chromatography=Mass Spectrometry. J. Mass Spectrom. 2005, 40, 785-795.
5. Boatto, G.; Nieddu, M.; Pirisi, M. A.; Dessi, G. Simultaneous Determination of New Thioamphetamine Designer Drugs in Plasma by Capillary Electrophoresis Coupled with Mass Spectrometry. Rapid Commun. Mass Spectrom. 2007, 21, 3716-3720.
6. Boatto, G.; Nieddu, M.; Dess, G.; Manconi, P.; Cerri, R. Determination of Four Thiophenethylamine Designer Drugs (2C-T-series) in Human Plasma by Capillary Electrophoresis with Mass Spectrometry Detection. J. Chromatogr. A 2007, 1159, 198-202.
7. Nieddu, M.; Boatto, G.; Pirisi, M. A.; Baralla, E. Multi-residue Analysis of Eight Thioamphetamine Designer Drugs in Human Urine by LC-MS=MS. Rapid Commun. Mass Spectrom. 2009, 23, 3051-3056.
8. Drummer, O. H.; Odell, M. The Forensic Pharmacology of Drugs of Abuse. Arnold: London, 2001.
9. Shulgin, A.; Shulgin, A. Pihkal. A Chemical Love Story, Transform Press: Berkeley, 1998.
10. Boatto, G.; Nieddu, M.; Carta, A.; Pau, A.; Palomba, M.; Asproni, B.; Cerri R. Determination of Amphetamine-derived Designer Drugs in Human Urine by SPE Extraction and Capillary Electrophoresis with Mass Spectrometry Detection. J. Chromatogr. B 2005, 814, 93-98.
11. Nieddu, M.; Boatto, G.; Dess, G. Determination of 4-alkyl 2,5-dimethoxyamphetamine Derivatives by Capillary Electrophoresis with Mass Spectrometry Detection from Urine Samples. J. Chromatogr. B 2007, 852, 578-581.
12. Nieddu, M.; Boatto, G.; Sini, L.; Dess, G. Determination of Paramethoxyamphetamine by Capillary Electrophoresis with Diode Array Detection from Urine and Plasma Samples. J. Liq. Chromatogr. Relat. Technol. 2007, 30, 431-438.
13. Nieddu, M.; Boatto, G.; Pirisi, M. A.; Azara, E.; Marchetti, M. LC-MS Analysis of Trimethoxyamphetamine Designer Drugs (TMA series) from Urine Samples. J. Chromatogr. B 2008, 867, 126-130.
14. Peters, F. T.; Drummer, O. H.; Musshoff, F. Validation of New Methods. Forensic Sci. Int. 2007, 165, 216-224.
15. Peters, F. T.; Maurer, H. H. Bioanalytical Method Validation and Its Implications for Forensic and Clinical Toxicology. Accred. Qual. Assur. 2002, 7, 441-449.
16. Taveniers, I.; De Loose, M.; Van Bockstaele, E. Analytical Method Validation and Quality Assurance. Trends in Anal. Chem. 2004, 23, 533-551.